Lyra Therapeutics Inc. (LYRA)
NASDAQ: LYRA
· Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.87
-2.69%
After-hours: Aug 15, 2025, 06:51 PM EDT
Lyra Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.44M | -8.55M | -10.98M | -11.87M | -48.13M | -22.45M | -15.16M | -15.65M | -15.62M | -16.25M | -14.23M | -19.55M | -14.48M | -7.01M | -13.62M | -11.05M | -11.04M | -7.8M |
Depreciation & Amortization | 127K | 128K | 151K | -1.97M | 145K | 136K | 85K | -68K | -23K | 284K | 222K | 279K | 286K | 280K | 278K | 350K | 303K | 70K |
Stock-Based Compensation | 914K | 825K | 1.94M | 1.49M | 1.12M | 2.16M | 1.48M | 1.44M | 1.35M | 1.61M | 1.76M | 1.74M | 1.11M | 844K | 782K | 733K | 656K | 599K |
Other Working Capital | n/a | n/a | -1.08M | 1.26M | 319K | -808K | -846K | 424K | -855K | -4.06M | -3.49M | 4.42M | 5.6M | -354K | 77K | -766K | 13.17M | -909K |
Other Non-Cash Items | -194K | -1.25M | -267K | -2.54M | 24.18M | -933K | 4.1M | -1.06M | 966K | -726K | 824K | 1.11M | 2.67M | 7.07M | 13.92M | 1.06M | 968K | 287K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -5.19M | n/a | n/a | n/a | n/a | n/a | -2.67M | n/a | -13.92M | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | -2.2M | -1.33M | 2.7M | -1.37M | -4.38M | 1.22M | -961K | -763K | -732K | 6.68M | 4.62M | -6.02M | 1.26M | -342K | 13.46M | -457K |
Operating Cash Flow | -6.59M | -8.84M | -11.35M | -16.22M | -19.98M | -22.45M | -19.06M | -14.11M | -14.28M | -15.85M | -12.16M | -10.85M | -8.47M | -11.9M | -11.3M | -10.31M | 3.38M | -7.59M |
Capital Expenditures | -20K | n/a | 58K | -51K | -196K | -2.15M | -787K | -144K | -71K | -45K | -28K | -29K | -14K | -93K | -1.08M | -517K | -625K | -1.16M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.84M | 490K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | -12.81M | -14.62M | -20.52M | -49.66M | -42.84M | -25.49M | -4.44M | -64.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 28.07M | 21M | 50.99M | 30.53M | 48.09M | 28M | 25M | 9.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 18K | n/a | n/a | n/a | n/a | n/a | n/a | -14.84M | -490K | n/a | -64.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2K | n/a | 28.13M | 8.14M | 36.18M | 7.86M | -2.36M | -14.98M | -561K | 5.32M | -64.87M | -29K | -14K | -93K | -1.08M | -517K | -625K | -1.16M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.64M | n/a | n/a | -23K | -98K | -166K | -322K | -420K | 47.19M | 4K | -196.99M | -236K | 96.49M | 6K | -4K | -84K | 185K | 262K |
Financial Cash Flow | 4.64M | n/a | -1K | -23K | -89K | 8.64M | 18.92M | -418K | 47.19M | 4K | -96.49M | -236K | 96.49M | 6K | -4K | -84K | 185K | 262K |
Net Cash Flow | -1.95M | -8.84M | 16.78M | -8.11M | 16.11M | -6.55M | -2.5M | -29.51M | 32.34M | -10.53M | -77.03M | -11.11M | 88M | -11.99M | -12.38M | -10.91M | 2.94M | -8.49M |
Free Cash Flow | -6.61M | -8.84M | -11.29M | -16.27M | -20.18M | -24.6M | -19.84M | -14.26M | -14.35M | -15.89M | -12.19M | -10.88M | -8.48M | -12M | -12.38M | -10.83M | 2.76M | -8.75M |